Dr. James V. Lynott, MD
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Medical school
- University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) (1999)
- Years since graduation
- 27
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 770
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1999Medical school: University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb)
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
WI license 46939-20 -
MOHS-Micrographic Surgery Physician
WI license 46939
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Forefront Dermatology Sc (662 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 770
- Services billed
- 9,084
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 3,151 | 458 |
| Established patient office or other outpatient visit, 20-29 minutes | 995 | 525 |
| Destruction of precancer skin growth, 1 growth | 830 | 513 |
| Ultrasonic guidance for placement of radiation therapy fields | 700 | 36 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 694 | 36 |
| Superficial and/or low voltage radiation treatment delivery | 669 | 36 |
| Biopsy of related skin growth, first growth | 318 | 271 |
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 247 | 11 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 215 | 179 |
| Established patient office or other outpatient visit, 10-19 minutes | 154 | 129 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 19 companies reported 241 payments worth $3,780 in total to this clinician.
| Sun Pharmaceutical Industries Inc. | $715 |
|---|---|
| AbbVie Inc. | $420 |
| Janssen Biotech, Inc. | $386 |
| Genzyme Corporation | $290 |
| UCB, Inc. | $275 |
| Regeneron Healthcare Solutions, Inc. | $269 |
| Mayne Pharma Commercial LLC | $266 |
| Leo Pharma Inc. | $256 |
| Food and Beverage | $3,628 |
|---|---|
| Education | $152 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. May 14, 2025 | Education DUPIXENT · IMMUNOLOGY AND INFLAMMATION · in-kind | $85.47 |
| Janssen Biotech, Inc. Jun 18, 2025 | Education TREMFYA · Immunology · in-kind | $66.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.